Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Vaxcyte Inc shares valued at $454,891 were sold by Dhaliwal Harpreet S. on Dec 31 ’25. At $46.69 per share, Dhaliwal Harpreet S. sold 9,743 shares. The insider’s holdings dropped to 23,928 shares worth approximately $1.08 million following the completion of this transaction.
Also, HARPREET DHALIWAL purchased 9,743 shares, netting a total of over 454,893 in proceeds.
Before that, Cowan Elvia had sold 11,623 shares from its account. In a trade valued at $556,972, the SVP, FINANCE traded Vaxcyte Inc shares for $47.92 each. Upon closing the transaction, the insider’s holdings decreased to 11,623 shares, worth approximately $0.66 million.
As published in a research note from Needham on January 07, 2026, Vaxcyte Inc [PCVX] has been retained to a Buy and the price target has been revised to $110. Analysts at Goldman started covering the stock with ‘”a Neutral”‘ outlook in a report released in mid September. As of April 22, 2025, Cantor Fitzgerald has initiated its “an Overweight” rating for PCVX. Earlier on December 20, 2024, Goldman initiated its rating. Their recommendation was “a Buy” for PCVX stock.
Analyzing PCVX Stock Performance
On last trading session, Vaxcyte Inc [NASDAQ: PCVX] plunged -1.61% to $45.32. The stock’s lowest price that day was $44.23, but it reached a high of $45.93 in the same session. During the last five days, there has been a drop of approximately -1.78%. Over the course of the year, Vaxcyte Inc shares have dropped approximately -47.30%. Shares of the company reached a 52-week high of $47.76 on 01/02/26 and a 52-week low of $43.94 on 01/05/26.
Support And Resistance Levels for Vaxcyte Inc (PCVX)
According to the 24-hour chart, there is a support level at 44.39, which, if violated, would cause prices to drop to 43.46. In the upper region, resistance lies at 46.09. The next price resistance is at 46.86. RSI (Relative Strength Index) is 47.97 on the 14-day chart, showing neutral technical sentiment.
Is Vaxcyte Inc subject to short interest?
Stocks of Vaxcyte Inc saw a sharp rise in short interest on 2025-12-15 jumping by 1.49 million shares to 10.83 million. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 9.34 million shares. A jump of 13.77% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 7.12 of the overall float, the days-to-cover ratio (short ratio) jumped to 7.12.
Which companies own the most shares of Vaxcyte Inc (PCVX)?
In terms of Vaxcyte Inc share price expectations, FactSet research, analysts set an average price target of 77 in the next 12 months, up nearly 67.17% from the previous closing price of $46.06. Analysts anticipate Vaxcyte Inc stock to reach 77 by 2026, with the lowest price target being 77. In spite of this, 6 analysts ranked Vaxcyte Inc stock as Buy at the end of 2026. On December 07, 2023, Mizuho assigned a price target of “a Buy” to the stock and initiated coverage with a $69.
